RMC
MRNA icon

Resources Management Corp’s Moderna MRNA Stock Holding History

Resources Management Corp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40
Closed -$2K – 306
2026
Q1 		$2K Hold
40
– – ﹤0.01% 382
2025
Q4 		$1K Sell
40
-20
-33% -$543 ﹤0.01% 411
2025
Q3 		$2K Hold
60
– – ﹤0.01% 390
2025
Q2 		$2K Sell
60
-895
-94% -$23.6K ﹤0.01% 397
2025
Q1 		$27K Sell
955
-533
-36% -$18.9K ﹤0.01% 310
2024
Q4 		$62K Sell
1,488
-135
-8% -$6.45K 0.01% 276
2024
Q3 		$108K Buy
1,623
+160
+11% +$14.7K 0.01% 262
2024
Q2 		$174K Sell
1,463
-55
-4% -$6.96K 0.03% 224
2024
Q1 		$162K Buy
1,518
+4
+0.3% +$403 0.02% 228
2023
Q4 		$151K Sell
1,514
-162
-10% -$13.6K 0.02% 235
2023
Q3 		$173K Buy
1,676
+45
+3% +$5.02K 0.03% 227
2023
Q2 		$198K Sell
1,631
-9,069
-85% -$1.21M 0.03% 216
2023
Q1 		$380K Buy
10,700
+9,410
+729% +$1.55M 0.06% 182
2022
Q4 		$232K Buy
1,290
+40
+3% +$6.54K 0.04% 219
2022
Q3 		$148K Buy
1,250
+35
+3% +$5.31K 0.03% 243
2022
Q2 		$174K Buy
1,215
+117
+11% +$16.7K 0.03% 239
2022
Q1 		$189K Buy
1,098
+121
+12% +$20.4K 0.03% 246
2021
Q4 		$248K Buy
977
+891
+1,036% +$261K 0.03% 238
2021
Q3 		$33K Buy
86
+11
+15% +$4.06K ﹤0.01% 344
2021
Q2 		$18K Hold
75
– – ﹤0.01% 379
2021
Q1 		$10K Hold
75
– – ﹤0.01% 409
2020
Q4 		$8K Sell
75
-75
-50% -$7.59K ﹤0.01% 419
2020
Q3 		$11K Buy
+150
New +$10.5K ﹤0.01% 371

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Resources Management Corp's MRNA Position: Q2 2026 in Review

Resources Management Corp sold out of Moderna (MRNA) in Q2 2026, closing a stake of 40 shares — an estimated $2K sold.

Resources Management Corp first reported a position in MRNA in Q3 2020 and held it in 23 quarters. The position peaked at $380K in Q1 2023. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Resources Management Corp reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Resources Management Corp sold 40 Moderna shares in Q2 2026, an estimated $2K.
  • Resources Management Corp first reported a position in Moderna in Q3 2020 and held it in 23 quarters.
  • Resources Management Corp's Moderna position peaked at $380K in Q1 2023.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Resources Management Corp's 13F filing for Q2 2026, filed 14 Aug 2026.